During this webinar on the 14.09.2023 from 5:00-6:00 p.m., moderated by John Rigney (GSK), the speaker Tony Pourmohamad (Genentech) will talk about "Opportunities for Bayesian Study Design: consideration of sequential Bayes factors for sample size reduction in preclinical experiments".
You can either register for the full series or individual webinars.
Find out more about the IQ Consortium here.